Stock listing
Biodesix, Inc.
Selected listing: BDSX · NASDAQ · USD · US
Biodesix, Inc. (NASDAQ:BDSX), Health Services. Latest release Sep 14, 2026: Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming…
- Ticker
- NASDAQ:BDSX
- Asset type
- Stock
- Sector
- Health Services
- Industry
- Medical/Nursing Services
- Exchange
- NASDAQ
- Currency
- USD
About Biodesix, Inc.
The company focuses on developing diagnostic solutions for patients with lung diseases. Biodesix aims to improve patient outcomes through innovative testing and personalized medicine approaches.
Latest news from Biodesix, Inc.
Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings
September 14, 2026
Biodesix Announces Second Quarter 2026 Results and Highlights
August 5, 2026
Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference
August 4, 2026
Biodesix to Report Second Quarter 2026 Financial Results on August 5, 2026
July 22, 2026
Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy
May 11, 2026